 As could be expected, the molecular diagnostics houses announcement of European approval of its Chinese investee companys COVID-19 test was greeted with a powerful share rally. The trouble is, some investors appear to have developed psychic powers and weighed in before the European regulators approval was announced to the market on Wednesday March 18. TBG ... 